GRUPO FINANCIERO GALICIA SA

GGAL

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

This signal appears mismatched to Driehaus's biotech focus—GGAL is an Argentine financial services company with no pharmaceutical operations or pipeline.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 1,236,833Value: $66.7M

This signal appears mismatched to Driehaus's biotech focus—GGAL is an Argentine financial services company with no pharmaceutical operations or pipeline. The $66.7M initiation likely reflects Driehaus's broader portfolio rebalancing into emerging markets or financials rather than a biotech-specific thesis, suggesting either sector diversification or a tactical macro bet on Argentine assets.

More GGAL Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: